PortfoliosLab logoPortfoliosLab logo

Loncar Cancer Immunotherapy ETF (CNCR) Alternatives

Loncar Cancer Immunotherapy ETF (CNCR) belongs to the Health & Biotech Equities category. Below you'll find alternative ETFs from the same category, ranked by key criteria, plus funds that investors commonly compare with CNCR. Use the tables to find lower-cost options, better risk-adjusted returns, or funds that fit a different role in your portfolio.

Cheapest Alternatives to CNCR

CNCR charges 0.79% annually. Among ETFs in the Health & Biotech Equities category, these options have the lowest expense ratios among CNCR alternatives.


Best Risk-Adjusted Alternatives to CNCR

Among ETFs in the Health & Biotech Equities category, these options rank highest on PortfoliosLab's risk-adjusted score, which accounts for volatility, drawdown, and return consistency over a 1-year period.


Top Performing CNCR Alternatives (YTD)

CNCR alternatives from the Health & Biotech Equities category, sorted by year-to-date return.


Lowest Volatility Alternatives to CNCR

CNCR alternatives from the Health & Biotech Equities category, sorted by annualized volatility over the past year.


Lowest Drawdown Alternatives to CNCR

CNCR alternatives from the Health & Biotech Equities category, sorted by maximum drawdown over the past year.


Other ETFs from Exchange Traded Concepts

Most popular Exchange Traded Concepts ETFs on PortfoliosLab, across asset classes.


Often Compared With CNCR

What investors most often compare with CNCR, based on PortfoliosLab usage data.


SymbolNameCategoryRisk / Return RankYTD ReturnInception
Schwab U.S. Dividend Equity ETFDividend
40
12.35%
Oct 20, 2011CNCR vs SCHD
VanEck Semiconductor ETFSemiconductors, Technology Equities
94
8.94%
Dec 20, 2011CNCR vs SMH
Vanguard Small-Cap ETFSmall Cap Growth Equities
46
2.99%
Jan 26, 2004CNCR vs VB
Invesco S&P 500 Momentum ETFS&P 500
58
-3.57%
Oct 9, 2015CNCR vs SPMO
iShares U.S. Healthcare ETFHealth & Biotech Equities
17
-5.01%
Jun 12, 2000CNCR vs IYH
JPMorgan Large Cap Growth Fund Class ALarge Cap Growth Equities
19
-7.70%
Feb 28, 1992CNCR vs OLGAX
Invesco S&P MidCap Momentum ETFMid Cap Growth Equities
71
6.80%
Mar 3, 2005CNCR vs XMMO
Invesco S&P MidCap Quality ETFMid Cap Blend Equities
31
1.89%
Dec 1, 2006CNCR vs XMHQ
F/m Emerald Life Sciences Innovation ETFHealth & Biotech Equities
87
-4.62%
Oct 30, 2024CNCR vs LFSC
ARK Genomic Revolution Multi-Sector ETFHealth & Biotech Equities, Actively Managed
36
-5.56%
Oct 31, 2014CNCR vs ARKG
Goldman Sachs Future Health Care Equity ETFHealth & Biotech Equities
16
-7.11%
Nov 9, 2021CNCR vs GDOC
First Trust Indxx Medical Devices ETFHealth & Biotech Equities
6
-9.27%
Jun 22, 2021CNCR vs MDEV
Simplify Health Care ETFHealth & Biotech Equities
36
-7.46%
Oct 7, 2021CNCR vs PINK
First Trust Nasdaq Pharmaceuticals ETFHealth & Biotech Equities
69
4.01%
Sep 20, 2016CNCR vs FTXH
First Trust Health Care AlphaDEX FundHealth & Biotech Equities
22
-2.85%
May 8, 2007CNCR vs FXH
VanEck Vectors Pharmaceutical ETFHealth & Biotech Equities
52
1.79%
Dec 20, 2011CNCR vs PPH
Invesco S&P 500 Equal Weight Health Care ETFHealth & Biotech Equities, S&P 500
16
-4.81%
Nov 1, 2006CNCR vs RSPH
Simplify Propel Opportunities ETFHealth & Biotech Equities
44
-0.79%
Feb 7, 2023CNCR vs SURI
WisdomTree BioRevolution FundHealth & Biotech Equities
79
4.67%
Jun 3, 2021CNCR vs WDNA
Global X HealthTech ETFHealth & Biotech Equities
3
-18.77%
Jul 29, 2020CNCR vs HEAL

Compare CNCR with Any Fund or Stock

Compare CNCR with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.


Loncar Cancer Immunotherapy ETF